Coal ministry unveils plan
Connect with us

Uncategorized

Coal ministry unveils plan to produce 1,404 MT per annum

Published

on

Coal

The Union Ministry of Coal said it has plans to produce 1,404 million metric tonnes (MT) of coal by the year 2027 and 1,577 MT by the year 2030, at the current level of production of about 1,000 MT per annum.
The coal to be supplied to domestic coal-based power plants is around 821 MT for the current year.
In a release, the ministry stated it has taken note of the additional coal requirement for supplying an additional 80 gigawatt thermal capacity to be added in the country by 2030.
The coal requirement for additional thermal capacity would be around 400 MT at an 85 percent plant load factor (PLF), and the actual requirement may be lower depending on the generation requirements in the coming years due to contributions from renewable sources.
“The Ministry of Coal has plans to produce an additional quantity of coal in its production enhancement plan and will ensure adequate availability of domestic coal to thermal power plants,” the ministry’s release said.
The production plan includes the opening of new mines, the expansion of mine capacity, and production from captive or commercial mines.
“The production plans for years 2027 and 2030 will far exceed the likely domestic requirement of thermal power plants in the country, including that for likely additional capacity.”
Coming to the coal situation for the current year, the ministry said stocks have started building up, and the coal stock at the thermal power plants is now around 20 MT and at the mines it is 41.59 MT. The total stock (including transit and captive mines) is 73.56 MT as compared to 65.56 MT during last year, showing growth of 12 percent year-on-year.
The Ministries of Coal, Power, and Railways are working in close coordination, and accordingly, smooth coal supplies have been maintained so far.
In other news, the Ministry of Coal is gearing up for the launch of the 8th round of auctions for commercial coal mines on Wednesday, taking a step forward towards making India self-reliant on coal.
The coal sector opened for commercial coal mining in 2020, with the first-ever successful auctions of commercial mining launched in June 2020. Since then, the ministry has conducted seven rounds of auctions, and 91 mines have been auctioned, with a peak rated capacity of 221 million tonnes per year, another release from the ministry stated.

The Daily Guardian is now on Telegram. Click here to join our channel (@thedailyguardian) and stay updated with the latest headlines.

For the latest news Download The Daily Guardian App.

Business

India’s overall exports in FY24 at $ 776.68 bn passes FY23 nos, trade deficit improves 35.77 %

Published

on

Overall trade deficit significantly improved by 35.77 per cent to USD 78.12 billion in FY24 from USD 121.62 billion in FY23.

Despite persistent global challenges, India’s overall exports (merchandise + services) in financial year 2023-24 (FY24) reached USD 776.68 billion, surpassing the USD 776.40 billion of overall exports achieved in 2022- 23 (FY23) with a growth of 0.04 per cent year-on-year as electronic goods, drugs and pharmaceuticals, engineering goods, iron ore, cotton yarn/fabs./made-ups, handloom products etc. and ceramic products and glassware delivered strong numbers. Overall imports in FY24 (April-March) declined 4.81 per cent at USD 854.80 billion. Overall trade deficit significantly improved by 35.77 per cent to USD 78.12 billion in FY24 from USD 121.62 billion in FY23.

The country’s robust performance in external trade is underlined by the highest monthly merchandise exports in March 2024 at USD 41.68 billion as compared to USD 41.96 billion in March 2023 while imports were USD 57.28Billion, as compared to USD 60.92 billion in March 2023. Services maintained upward momentum with India exporting USD 339.62 billion of services in FY24 compared to USD 325.33 billion in FY23. The country achieved services trade surplus of USD 162.05 billion in FY24 with services imports coming at USD 177.56 billion in FY24 as compared to USD 182.05 billion in FY23.

Ashwani Kumar, President, FIEO points out that the achievement in overall export figures for the FY24 is impressive despite Russia Ukraine war, Red Sea crisis, tight monetary stance by the developed world and falling commodity prices posing challenges. Aditi Nayar Chief Economist ICRA notes that India’s merchandise trade deficit eased to an 11-month low of USD15.6 billion in March 2024, led by a larger yoy decline in merchandise imports vis-à-vis such exports, while also trailing the levels seen in the year-ago month. This comes amid a halving of gold imports and a fall in non-oil non-gold imports. “This is expected to augur well for the current account number in Q4 FY2024, which may witness a small, transient surplus of USD1-2 billion in the quarter,” says Nayar.

On a slight downside, in FY24, merchandise exports declined to USD 437.06 billion as against USD 451.07 billion during FY23 while imports came down to USD 677.24 billion as against USD 715.97 billion during FY 23. This however, lowered merchandise trade deficit for FY 24 at estimated at USD 240.17 billion as against USD 264.90 billion during FY 23. India’s exports of merchandise and services combined in March 2024 at USD 70.21 billion also dipped 3.01 per cent over March 2023 while overall imports in March 2024 at USD 73.12 billion, exhibited a negative growth of 6.11 per cent over March 2023. Overall trade deficit is estimated to significantly improve by 35.77% from USD 121.62 Billion in FY 2022-23 to USD 78.12 Billion in FY 2023-24; Merchandise trade deficit improves by 9.33% at USD 240.17 Billion in the current FY as compared to USD 264.90 Billion in FY 2022-23.

Among main drivers of merchandise export growth in FY 2023-24, non-petroleum and non-gems and jewellery goods which comprises basket of gold, silver and precious metals, grew to USD 33.67 billion, compared to USD 30.87 billion in March 2023. The same basket of imports in March 2024 were USD 35.21 billion, compared to USD 36.51 billion in March 2023. In FY24, non-petroleum and non-gems and jewellery exports increased by 1.45 per cent to USD 320.21 billion, as compared to USD 315.64 billion in FY23. The imports of this basket of goods were USD 422.80 billion in FY24 compared to USD 435.54 billion in FY23.

In a sectoral show of strength, electronic goods exports increased by 23.64 per cent from USD 23.55 billion in FY 2022-23 to USD 29.12 billion in FY 2023-24 while drugs and pharmaceuticals exports increase by 9.67 per cent from USD 25.39 billion in FY 2022-23 to USD 27.85 billion in FY 2023- 24. Engineering goods exports increased by 2.13 per cent from USD 107.04 billion in FY 2022-23 to USD 109.32 billion in FY 2023-24. Exports of agricultural commodities namely tobacco grew 19.46 per cent, fruits and vegetables grew 13.86 per cent, meat, dairy and poultry products grew 12.34 per cent, spices grew 12.30 per cent, cereal preparations and miscellaneous processed items grew 8.96 per cent, oil seeds grew 7.43 per cent and oil meals exhibited positive growth of 7.01 per cent.

Continue Reading

Uncategorized

Homes priced above INR 1 cr corner highest share ever in total sales, says report

Published

on

Sales of properties priced below Rs 50 lakh record dip in sales in the January-March quarter, according to Knight Frank.

According to a report released on Thursday by real estate consultancy Knight Frank, homes priced above Rs 1 crore commanded their largest-ever share of total sales, reaching 40 percent in the quarter ending on March 31. This marks a significant increase from the previous quarter’s 39 percent. The trend of such high-end homes gaining market share has been consistent, with their proportion steadily rising from 29 percent in Q1 2023 to 35 percent in Q3 of the same year.

The report, titled ‘India Real Estate: Office and Residential Report,’ highlights that between January and March 2024, a total of 34,895 homes priced above Rs 1 crore were sold, marking a substantial 51 percent increase compared to the same quarter in 2023. This surge in sales contributed to the overall growth in the residential market, with a total of 86,345 units sold in this price category, representing a 9 percent increase from Q1 2023 and the second-best quarter on record, following closely behind Q4 2023.

Shishir Baijal, chairman and managing director at Knight Frank India, commented on this trend, stating, “This not only demonstrates a strong demand trajectory but also reflects buyers’ confidence in making long-term commitments.”

Conversely, homes priced below Rs 50 lakh and between Rs 50 lakh and Rs 1 crore experienced a decline in sales volume. Sales of homes below Rs 50 lakh dropped from 25,714 units in Q1 2023 to 23,026 units in Q1 2024, accounting for 27 percent of total sales, significantly lower than its peak of 41 percent in Q1 2022. Similarly, homes priced between Rs 50 lakh and Rs 1 crore saw a 6 percent decrease in sales during the quarter, with 28,424 units sold, representing 33 percent of total sales, down from 38 percent last year.

The report also highlighted regional trends, indicating that the majority of homes priced above Rs 1 crore were sold in the National Capital Region (NCR), totaling 10,558 units, followed by Mumbai (7,401) and Hyderabad (6,112). In the NCR specifically, these high-end homes accounted for 68 percent of the total sales volume.

Continue Reading

Uncategorized

WHO reports 8.6% surge in TB deaths in South-East Asia in 2021

Published

on

The tuberculosis mortality rate in the Southeast Asia region saw a rise of 8.6 percent in 2021 as compared to 2015, according to an official release from the World Health Organization (WHO).

According to the release, the regional director of WHO, South-East Asia Region, Saima Wazed, said, “The TB mortality rate in the region increased by 8.6 percent in 2021 compared to 2015. The probability of death between the ages of 30 and 70 from four major diseases—cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases—is still unacceptably high at 21.6 percent.”

She added that the poorest and groups with vulnerabilities face the greatest barriers to accessing needed healthcare, often with catastrophic consequences for their health and well-being.

“Poor quality care accounts for more diseases and deaths than lack of access to care,” she said. The Regional Director stated further that gender inequality affects equitable access to diagnosis and treatment of non-communicable health conditions.

The WHO will focus the spotlight on the theme ‘My Health, My Right’ on World Health Day this year on April 7. According to an official press release from WHO, South East Asia, “In a world witnessing multiple crises, from diseases to disasters to conflicts and climate change, realizing people’s right to health is now more important than ever. To mark the foundation of the World Health Organization, the spotlight this year is on ‘My Health, My Right’, on World Health Day, celebrated on April 7.”

Wazed also expanded on the significance of acknowledging the ‘Right to Health’ for all. “Realizing the right to health for all means creating conditions where everyone, everywhere, can access high-quality health facilities, services, and goods that prioritize people’s needs, understanding, and dignity,” Wazed said. “It also means a full set of rights that enable people to live healthily, such as education, safe water and food, nutritious food, adequate housing, good working and environmental conditions, and information—or the underlying determinants of health,” she added. “To fulfill the right to health, both health services and the underlying determinants should be available, accessible, acceptable, and of adequate quality,” she said.

The right to the highest attainable standard of mental and physical health—or the right to health—has been core to the WHO’s mission, globally and in the region. It is enshrined in the WHO’s Constitution.

As WHO marks its seventy-sixth year on April 7, the Southeast Asia Region has seen many gains and has much to celebrate about the right to health. “The Universal Health Coverage Service Coverage Index has improved from 47 in 2010 to 62 in 2021. The average density of medical doctors, nurses, and midwives in the region stands at 28.05 per 10,000 population, up by 30.5 percent since 2015,” she said. “The region achieved a 68.5 percent reduction in the maternal mortality ratio between 2000 and 2020. The under-five mortality rate declined significantly from 84 per 1000 live births in 2000 to 29 per 1000 live births in 2021, and the neonatal mortality rate declined from 41 per 1000 live births in 2000 to 17 per 1000 live births in 2021. Between 2015 and 2021, new HIV infections declined by 25 percent and malaria incidence by 62 percent,” she added.

However, despite progress, we still have a considerable way to go to make the right to health a reality for all in the WHO South-East Asia Region, the Regional Director said. She added that despite global commitments to the right to health, nearly 40 percent of the region’s people lack coverage of essential health services. Investment in health by national governments, which is the foundation of advancing the right to health, is unacceptably low, which has resulted in high out-of-pocket expenditures, according to the release. The proportion of households experiencing financial hardship in accessing basic health care has been rising.

“Violence against women and girls—a violation of their human rights and a priority public health issue—remains pervasive. More than one in every three women in the region has experienced intimate partner violence at least once in their lifetime, with rural and uneducated women and those from the poorest households facing a significantly higher risk,” she said.

“Too many still face stigma related to certain health conditions, such as TB, HIV/AIDS, disability, or mental illness. They also face discrimination in the health system based on their gender, class, ethnicity, religion, sexual orientation, or other characteristics,” the Regional Director said.

Wazed stated that equality and non-discrimination are core to a human rights-based approach to health. “A human rights-based approach also entails adherence to the principle of participation. For example, by ensuring that those most affected by certain health conditions or health policies and decisions have a say in how these decisions are made,” she said.

“Accountability is also integral to a human rights-based approach. For example, reporting back to affected groups and communities about the performance of the health system or health programs to address their needs,” she said.

All governments and other duty-bearers must respect, protect, and fulfill the right to health and other human rights, and to ensure their progressive realization, the WHO release went further, adding, “Governments need to increase investments in health—especially to advance universal health coverage grounded in a primary health care approach.

“Good laws can lay the foundation for more effective tobacco control, environmental protection, better nutrition, control of obesity and cardiovascular diseases, fair and equal working conditions, and much more. Health services need to be made more available, accessible, acceptable, and of better quality for all,” Wazed said.

“WHO is committed to advancing the right to health and other human rights. Let’s make the right to health a reality for all,” she added.

Continue Reading

Economic

Lanka Economy Records 4.5% Surge in Q4 2023: Central Bank

Published

on

Sri Lanka’s bankrupt economy is expected to grow by 4.5 per cent year-on-year in the fourth quarter of 2023, following six consecutive negative quarters. In February, the Central Bank reported a decrease in headline inflation to 5.9 per cent from 6.4 per cent in January. The gross official reserves improved to 4.5 billion dollars by the end of February 2024. This includes a swap facility from the People’s Bank of China.

The Central Bank announced on Tuesday that Sri Lanka’s economy, which had been experiencing six successive quarters of negative growth, is estimated to have recorded a growth of 4.5 per cent year-on-year in the fourth quarter of 2023. Positive growth was only seen in the third quarter of 2023, following six successive quarters of negative growth experienced by the cash-strapped economy.

The headline inflation, as measured by the year-on-year change in the Colombo Consumer Price Index, had decelerated to 5.9% in February from 6.4% in January. The gross official reserves improved to 4.5 billion dollars by the end of February 2024, which includes the swap facility from the People’s Bank of China. Governor Nandalal Weerasinghe said the reserve buildup was better than the Central Bank’s expectations. “The reserve buildup was supported by considerable net purchases by the Central Bank from the domestic foreign exchange market amidst increased foreign currency inflows compared to outflows,” Weerasinghe said. “The Sri Lankan rupee, which appreciated by 12.1% against the US dollar in 2023, continued to show an appreciation of 6.7% thus far in 2024,” he said.

Governor Weerasinghe said the agreements on debt restructuring with sovereign bond-holders could be completed by June in time for the next review of the International Monetary Fund (IMF) bailout programme. Governor said despite the sovereign default, the commercial loans granted by India along with currency swaps with the Reserve Bank of India (RBI) continue to be serviced. In early 2022, amidst the onset of the economic crisis, India’s provision of a 4 billion USD assistance package served as a vital lifeline for Sri Lanka, enabling the importation of fuel and essential goods.

Continue Reading

Uncategorized

Exploring How Japan’s Medical Technology Fuels India’s Healthcare Landscape

Published

on

Statistics suggest that India has approximately 2.8 million hospital beds, including both private and public. Therefore, there are 1.7 beds per 1,000 people in comparison with developed nations that have around 2.5 to 3.

Amidst the escalating global disease burden, healthcare providers worldwide are intensifying efforts to expedite delivery systems and implement more precise treatment therapies, aiming for swifter patient recovery outcomes. Correspondingly, healthcare stakeholders in India are actively enhancing procedures for high-risk treatments, striving for greater precision and efficacy.

Concurrently, the Indian government’s successful efforts in attracting major global medical device players from countries like Japan, Germany, and the USA have facilitated the introduction of advanced devices and therapies, revolutionizing treatment methodologies and improving treatment outcomes for high-risk diseases. Medical Technology Association of India (MTaI) has earlier recommended Japan as the preferred choice for medtech imports instead of China. Notably, India’s policy allowing 100% Foreign Direct Investment (FDI) under automatic routes for both Greenfield and Brownfield setups has encouraged global investors to participate in the healthcare sector.

The burgeoning adoption of Japanese medical technology in India marks a significant shift in the nation’s healthcare landscape, promising ground breaking innovations and collaborations that stand to revolutionize healthcare delivery nationwide. This trend is propelled by Japan’s renowned expertise in precision engineering and advanced medical devices, with Japanese companies leading the development of cutting-edge technologies in areas like diagnostic imaging, surgical robotics, and regenerative medicine. Collaborations between Japanese and Indian firms have played a pivotal role.

These collaborations facilitate technology and knowledge transfer, empowering Indian healthcare providers to leverage Japanese expertise while tailoring solutions to local needs. The contribution of Japan also extends notably to advancing cardiovascular treatment methodologies in India. One of the noteworthy instances of investment involves Terumo India’s introduction of Ultimaster Nagomi, a Drug Eluting Stent (DES) for treating coronary artery disease, reflecting their commitment to investing in next-generation stents to enhance the safety and efficacy of coronary artery treatments in India. Additionally, Terumo India recently unveiled innovative therapies like B-TACE for managing liver cancer in India. Through Occlusafe, Terumo’s B-TACE device offers patients a more precise and targeted delivery of chemotherapy drugs to the tumour, while minimizing damage to surrounding healthy tissues.

Numerous other investments are made in India, such as Omron Healthcare’s manufacturing unit launch in Tamil Nadu and the collaboration between Japan Lifeline and Meril Sciences to promote medical devices or therapies. Statistics suggest that India has approximately 2.8 million hospital beds, including both private and public. Therefore, there are 1.7 beds per 1,000 people in comparison with developed nations that have around 2.5 to 3. Despite India’s cadre of proficient doctors and expanding healthcare infrastructure, comprehensive coverage remains elusive, hindering healthcare accessibility for many.

Addressing this challenge is crucial for optimizing the country’s healthcare resources and ensuring equitable access to healthcare opportunities. Further, the country needs to reduce the cost of healthcare and invest in technology to create better patient experience and clinical outcomes. As India grapples with healthcare challenges amid rapid urbanization, demographic shifts, and the burden of non-communicable diseases, the influx of Japanese medical technology offers hope.

By embracing innovation and forging strategic partnerships, India stands to leverage Japanese expertise for a healthier and more prosperous future. The surge of Japanese medical technology in India signifies not only technological advancement but also the power of collaboration and shared vision in driving positive change in healthcare delivery, promising transformative impacts across the Indian subcontinent.

Continue Reading

Infrastructure Development

NHAI completes largest monetisation of over Rs16,000 cr through InvIT

Published

on

National Highways Infra Trust (NHIT) has successfully concluded fundraising for national highway stretches of aggregate length of 889 kilometres. The NHIT is the infrastructure investment trust (InvIT) by the National Highways Authority of India (NHAI) and serves like a mutual fund, which enables direct investment of money from individual and institutional investors in infrastructure projects to earn a portion of the income as return. The largest ever by NHAI monetisation of over Rs 16,000 crore has been caried out through Round 3 ’InvIT and is one of the largest transactions in the history of Indian road sector.

The Letter of Acceptance (LOA) to raise the highest ever concession value through ’InvIT Round-3’ was issued last month in February 2024. Since November 2021, NHIT has cumulatively raised around Rs.12,000 crore through first two rounds of monetisation for acquisition of eight operating road assets with an aggregate length of 636 km from NHAI. Historically, units of NHIT were issued at a price of Rs 101 in November 2021 and were listed on both BSE and NSE. According to Anurag Jain, Secretary, Ministry of Road Transport & Highways, the NHIT is a successful example of public private partnership in which it has played a very important role in supporting national monetisation pipeline. While doing that NHIT has established itself as a leading player in the InvIT space, playing a critical role in channelising financial capital into the further development of Indian roads sector.

In the third round of monetisation, NHIT has raised unit capital of around Rs 7,272 crore from marquee domestic and international investors and debt of around Rs 9,000 crore from Indian lenders, to fund the acquisition of National Highway stretches, at a base concession fee of around Rs 15,625 crore, and additional concessional fees of Rs 75 crore. The units were subscribed by investors through a book build process at a cut off price of Rs 124.14 per unit, at a premium over the current NAV of Rs 122.86 per unit.

The units witnessed strong demand from both existing and new investors, including foreign pension funds viz. Canada Pension Plan Investment Board and Ontario Teachers’ Pension Plan Board, which are existing unitholders and subscribed to the maximum limit of 25 per cent each. The other investors included domestic pension/provident funds (IOCL Employee’s PF, L&T Staff PF, Rajasthan Rajya Vidyut Karamchari Pension Fund, SBI Pension etc.), insurance companies (Tata AIG, SBI Life, HDFC Life), mutual funds (SBI, Nippon India), banks and few others. NHAI also subscribed to its share of ~15% of the units at the same price.

With completion of the third round of monetisation the total realised value of all three rounds of InvIT stands at Rs 26,125 crore and holds a diversified portfolio of fifteen operating toll roads with an aggregate length of about 1,525 km spread across the 9 states of Assam, Gujarat, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Telangana, Uttar Pradesh and West Bengal, with concession periods ranging between 20 to 30 years. The National Highways Infra Trust (NHIT), the Infrastructure Investment Trust sponsored by National Highways Authority of India (NHAI), was set up in 2021 to support Government of India’s National Monetization Pipeline.

Santosh Kumar Yadav, NHAI Chairman expects the successful completion of the largest monetisation of roads for NHAI to continue to play a stellar role in the monetisation and development of the Indian roads sector.

Continue Reading

Trending